Edition:
United Kingdom

TRACON Pharmaceuticals Inc (TCON.OQ)

TCON.OQ on NASDAQ Stock Exchange Global Market

0.96USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$0.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
42,257
52-wk High
$3.15
52-wk Low
$0.50

Chart for

About

TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company's research focuses on antibodies that bind to the endoglin receptor, which is... (more)

Overall

Beta: --
Market Cap(Mil.): $61.63
Shares Outstanding(Mil.): 16.66
Dividend: --
Yield (%): --

Financials

  TCON.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -1.76 -- --
ROI: -107.08 8.99 14.48
ROE: -146.37 10.13 15.99

Earnings vs. Estimates